Post by BiotechNews

Outstanding science alone is rarely enough to build a successful biotech company. Many scientists spend years developing groundbreaking innovations, yet fundraising often proves to be an entirely different challenge. Bridging the gap between scientific excellence and investor expectations requires a different skill set: storytelling, strategy, and understanding what investors are really looking for. In this interview by our partner BioPitch, Max Seignette, founder of Ensemblate and the new fundraising platform RAISE, explains why so many life sciences founders struggle to raise capital - and how smarter investor targeting and better preparation can dramatically improve their chances of success. His message is clear: founders shouldn't spend countless hours chasing the wrong investors. They should spend more time building relationships, refining their story, and advancing the innovations that can make a real difference. Read the full interview on BiotechNews, the online news and media platform and magazine with a focus on the Dutch and Belgium Life Sciences & Health sector. Get a free subscription via the website or follow BiotechNews on LinkedIn to stay up to date on the developments in the Life Sciences sector. https://lnkd.in/ed7NPyvN